Medicamen Biotech Fundamental Analysis
MEDICAMEQ
323.0515.55 (5.06%)
Last updated on 11 Sep, 2026 | 15:59 IST
Free Demat with Zero AMC*
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC
Medicamen Biotech Fundamentals
P/E Ratio
40.52
P/B Ratio
1.62
Div. Yield
0.31
Sector P/E
41.67
Sector P/B
3.62
Sec. Div. Yield
0.51
Medicamen Biotech Fundamentals is currently trading with a P/E Ratio of 40.52, compared to the sector average of 41.67. Its P/B Ratio stands at 1.62, while the sector’s is 3.62. In terms of returns, the stock offers a Dividend Yield of 0.31%, which is than the sector’s 0.51%.
Medicamen Biotech Score Card
Price
Attractive
Growth
Poor
Quality
Poor
Management
Average
On its scorecard, Medicamen Biotech reflects: Price – Attractive, Growth – Poor, Quality – Poor, and Management – Average. Together, these indicators provide a structured view of the company’s fundamentals.
Medicamen Biotech Associated Pages
Open Your Free
Demat Account Now!
AMC for First Year
Auto Square Off Charges
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools

Open Your Free
Demat Account Now!
AMC For First Year
Account Opening Fee
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools
Invest in MEDICAMEQ
Account Opening Fee
AMC for 1st Year
Auto Square Off Charges
Call & Trade
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC